Paige Hickson, PA
Medical · Portage, MINPI 1568425973
Payments from drug & device makers
Across 187 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$381
- Sun Pharmaceutical Industries Inc.$380
- Sanofi$332
- Lilly USA, LLC$304
- Johnson & Johnson$300
- Dermavant Sciences, Inc.$275
- plus $2K from 16 others
What the payments were for
- Food & beverage$3,42494%
- Education$2156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $381 |
| Sun Pharmaceutical Industries Inc. | 17 | $380 |
| Sanofi | 13 | $332 |
| Lilly USA, LLC | 15 | $304 |
| Johnson & Johnson | 9 | $300 |
| Dermavant Sciences, Inc. | 34 | $275 |
| Regeneron Healthcare Solutions, Inc. | 10 | $271 |
| Amgen | 11 | $209 |
| Pfizer | 9 | $183 |
| UCB, Inc. | 6 | $157 |
| Arcutis Biotherapeutics, Inc. | 6 | $140 |
| Organon | 13 | $138 |
| LEO Pharma Inc. | 6 | $119 |
| E.r. Squibb & Sons, L.L.C. | 5 | $111 |
| Fresenius Kabi USA, LLC | 4 | $99 |
| Boehringer Ingelheim | 3 | $79 |
| Almirall LLC | 2 | $47 |
| Genentech USA, Inc. | 1 | $34 |
| Novartis | 1 | $28 |
| Incyte Corporation | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
How this compares
$3,640 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 26 | $191,252 |
| Taltz AutoinjectorIxekizumab | 12 | $144,604 |
| Dupixent PenDupilumab | 30 | $116,735 |
| Humira(Cf) PenAdalimumab | 16 | $110,477 |
| Betamethasone Dipropionate | 121 | $5,114 |
| Fluorouracil | 55 | $3,347 |
| Metronidazole | 46 | $2,922 |
| Ketoconazole | 151 | $2,561 |
| Ciclopirox | 48 | $2,405 |
| Clobetasol Propionate | 73 | $2,358 |
| Clindamycin Phosphate | 50 | $2,286 |
| Betamethasone Valerate | 50 | $1,877 |
| Fluticasone Propionate | 70 | $1,633 |
| Tretinoin | 27 | $1,618 |
| Triamcinolone Acetonide | 157 | $1,545 |
Paid to pharmacies, not to this prescriber.
Other medical in Portage
- Jacqueline JamesPortage$8K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.